CASC2 and adenocarcinoma: miR-4735-3p has previously been described to target mammalian target of rapamycin (mTOR)-dependent signaling, by interacting with the long non-coding (lnc) RNA Cancer Susceptibility 2 (CASC2) that plays an important role in inhibiting proliferation and migration of adenocarcinoma cells.26